Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthracyclines-Induced Cardiotoxicity”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Testing effectiveness (Phase 2)Looking for participantsNCT03934905
What this trial is testing

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Who this might be right for
Anthracycline Related Cardiotoxicity in Breast Cancer
Texas Tech University Health Sciences Center 70
Not applicableUnknownNCT06331806
What this trial is testing

Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity

Who this might be right for
Cardiomyopathy Due to Drug
European Institute of Oncology 100
Post-approval studies (Phase 4)Looking for participantsNCT06491680
What this trial is testing

Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer
Helwan University 40
Not applicableEnded earlyNCT00728429
What this trial is testing

Aerobic Exercise in Patients Receiving Chemotherapy for Cancer

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Wake Forest University Health Sciences 1
Not applicableUnknownNCT03748550
What this trial is testing

Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)

Who this might be right for
Cancer, BreastCardiotoxicityCardiovascular Diseases
Nova Scotia Health Authority 7
Testing effectiveness (Phase 2)Looking for participantsNCT05732051
What this trial is testing

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac Dysfunction+2 more
University Hospital, Akershus 60
Not applicableEnrolling By InvitationNCT01173341
What this trial is testing

Cardiotoxicity of Cancer Therapy (CCT)

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 700
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Not applicableStudy completedNCT01805778
What this trial is testing

Preventing Cardiac Sequelae in Pediatric Cancer Survivors

Who this might be right for
Anthracycline-induced Cardiotoxicity
The Hospital for Sick Children 1,128
Large-scale testing (Phase 3)UnknownNCT05728632
What this trial is testing

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

Who this might be right for
Breast CancerLymphoma, Large B-Cell, DiffuseCardiotoxicity+2 more
Giulio Stefanini 80
Large-scale testing (Phase 3)UnknownNCT04030546
What this trial is testing

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Who this might be right for
Patients With Cancer
Vilnius University 128
Testing effectiveness (Phase 2)Study completedNCT06888505
What this trial is testing

Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity

Who this might be right for
Anthracyclines-Induced CardiotoxicityCardiotoxicity
Hawler Medical University 94
Not applicableStudy completedNCT03553654
What this trial is testing

Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity

Who this might be right for
Neoplasms
University of California, San Diego 19
Not applicableLooking for participantsNCT07191730
What this trial is testing

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Who this might be right for
CardiotoxicityHeart FailureNeoplasms+1 more
University Hospital, Caen 600
Not applicableStudy completedNCT03940625
What this trial is testing

Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping

Who this might be right for
Breast CancerMyocardial DamageCardiotoxicity
Heinrich-Heine University, Duesseldorf 69
Not applicableLooking for participantsNCT06282796
What this trial is testing

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
First Hospital of China Medical University 600
Not applicableStudy completedNCT02916316
What this trial is testing

Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

Who this might be right for
LymphomaLarge B-CellDiffuse Large B-Cell
Fondazione Italiana Linfomi - ETS 127
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370506
What this trial is testing

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Tanta University 36
Post-approval studies (Phase 4)UnknownNCT04939883
What this trial is testing

Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy

Who this might be right for
Cancer
Hospital Sirio-Libanes 1,018
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07572175
What this trial is testing

Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity

Who this might be right for
Anthracycline-induced CardiotoxicityLymphomaChemotherapy+1 more
Icahn School of Medicine at Mount Sinai 60
Next Page